This week’s newsletter covers regenerative cannabis growing practices, a clinical critique of a new FDA study on CBD and liver health, and the latest research on CBD’s antitumor effects, cannabis oils and liver damage, and psilocybin’s potential in traumatic brain injury recovery.
Noteworthy Read
How Regenerative Cannabis Expresses Its Fullest Potential in Nature (Emerald Magazine)
This article from Emerald Magazine explores the principles of regenerative cannabis cultivation, emphasizing practices that go beyond sustainability to actively restore soil health, biodiversity, and ecological balance. By integrating cannabis into living ecosystems rather than industrialized systems, growers can cultivate plants with richer terpene profiles and greater therapeutic potential.
More Noteworthy Reading
Does Low-Dose CBD Pose a Risk to Liver Health? (Project CBD)
A recent clinical trial raises questions about the safety of widely consumed CBD capsules, gummies, edibles, oils and lotions that are omnipresent in the United States and many other countries. But pioneer cannabis clinician Bonni Goldstein, MD, cautions patients and physicians not to overstate the findings of the new FDA study, which was published in JAMA Internal Medicine. Project CBD has published a summary of the trial results followed by comments from Dr. Goldstein, the CEO and co-founder of GoldsteinWellness.com, a free medical cannabis educational platform for licensed healthcare clinicians, and Medical Director of Canna-Centers in California.
Read the full article
View more in CBD
Research Round-Up
Antitumor Effects of CBD on Osteosarcoma (ScienceDirect)
A new preclinical study highlights cannabidiol’s (CBD) ability to inhibit osteosarcoma cell growth and metastasis, suggesting its potential as a therapeutic agent for this aggressive bone cancer.
Study Finds Cannabis Oils with THC and CBD Reduce Liver Damage (Marijuana Herald)
Researchers have found that full-spectrum cannabis oils containing both THC and CBD significantly reduced biomarkers of liver damage in a recent animal model study.
Potential Role of Psilocybin in Traumatic Brain Injury Recovery (MDPI)
A review suggests psilocybin may promote neuroplasticity and cognitive recovery following traumatic brain injury (TBI), though clinical trials are still needed to verify safety and efficacy.
Read more
View more in Psychedelics
A heartfelt thank you to all of the CBD brands whose generous support makes it possible for Project CBD to shine a light on the plant medicine research that matters most. We are deeply grateful for your partnership in this important work.
